MT Newswires
Truist Adjusts Price Target on Revolution Medicines to $116 From $99, Maintains Buy Rating
📈
AI Sentiment
Highly Positive
8/10
- Home
- RVMD
as of 02-27-2026 11:06am EST
$102.48
+$0.33
+0.32%
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 15.2B | IPO Year: | N/A |
| Target Price: | $114.63 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $29.17 - $124.49 | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | 552.08% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
AI-Powered RVMD Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 16 hours ago
AI Recommendation
hold
Model Accuracy: 65.81%
65.81%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Revolution Medicines Inc. News
RVMD Breaking Stock News: Dive into RVMD Ticker-Specific Updates for Smart Investing
MT Newswires
Truist Raises Price Target on Revolution Medicines to $116 From $99, Keeps Buy Rating
📈
AI Sentiment
Highly Positive
8/10
Insider Monkey
Evercore ISI Initiates Revolution Medicines (RVMD) With an Outperform Rating – Here’s Why
📈
AI Sentiment
Highly Positive
9/10
Zacks
RVMD Reports Wider-Than-Expected Q4 Loss, Issues 2026 Expense View
📉
AI Sentiment
Negative
3/10
Insider Monkey
Has Revolution Medicines (RVMD) Found a Breakthrough in Cancer Treatment?
📊
AI Sentiment
Positive
6/10
Compare RVMD vs Leading Stocks
See how RVMD stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "RVMD Revolution Medicines Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.